Related Experiment Video
Updated: Oct 31, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease
Carlos Ramirez Alvarez1, Carmon Kee2,3, Ashwini Kumar Sharma1
1Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
The serine protease TMPRSS2 aids SARS-CoV-2 entry. SPINT2 inhibits TMPRSS2, and its reduced expression in COVID-19 patients correlates with increased viral load, suggesting a therapeutic target.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) entry into host cells is facilitated by the serine protease TMPRSS2.
- The regulation of TMPRSS2 activity is crucial for understanding viral pathogenesis, yet remains largely uncharacterized.
- SPINT2, a Kunitz-type serine protease inhibitor, is known to inhibit TMPRSS2 activity.
Purpose of the Study:
- To investigate the co-regulation between SPINT2 and TMPRSS2.
- To determine the role of SPINT2 in SARS-CoV-2 infection and its potential link to COVID-19 comorbidities.
Main Methods:
- Analysis of SPINT2/TMPRSS2 expression balance across various tissues.
- Correlation analysis of SPINT2 expression with SARS-CoV-2 replication in Calu-3 and Caco-2 cell lines.
- SPINT2 knockdown and overexpression experiments in Calu-3 cells to assess viral load.
- Evaluation of SPINT2 expression in datasets from comorbid diseases (cancer, diabetes) using bulk and single-cell RNA sequencing.
Main Results:
- A tightly regulated expression balance between SPINT2 and TMPRSS2 was observed across tissues.
- SPINT2 expression negatively correlated with SARS-CoV-2 in lung and intestinal cell lines.
- SPINT2 was down-regulated in secretory cells of COVID-19 patients.
- SPINT2 knockdown increased viral load, while overexpression reduced it in Calu-3 cells.
- SPINT2 down-regulation was noted in colon, kidney, and liver tumors, and in pancreatic islet cells from Type 2 diabetes patients.
Conclusions:
- SPINT2 acts as a crucial regulator of TMPRSS2 activity, impacting SARS-CoV-2 entry and replication.
- Down-regulation of SPINT2 may contribute to increased viral load in COVID-19 patients.
- Altered SPINT2 expression in comorbid conditions suggests a potential link to COVID-19 severity and pathogenesis in patients with chronic diseases.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Single Nucleotide Polymorphisms-SNPs
Leaky Scanning
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibition of Cdk Activity

